Redox cofactor
NAD+/NADH couples transfer reducing equivalents in metabolic enzyme reactions.

Product images are for illustrative reference only. Final label layout and packaging details may vary by batch or production run. Product identity, strength and batch-specific documentation are provided separately and remain product-specific.
NOREXA PEPTIDES / RESEARCH MATERIAL
Lyophilized Compound — Single vial
NAD+ 500 mg supplied exclusively as a laboratory research material. Available batch documentation is published only under its corresponding batch record.
Not for human or animal consumption.
Not intended to diagnose, treat, cure or prevent any disease.
RESEARCH & TECHNICAL OVERVIEW
Nicotinamide adenine dinucleotide (NAD+) is an endogenous dinucleotide cofactor present in living cells. It participates in oxidation–reduction chemistry and also serves as a substrate for signalling enzymes including sirtuins, poly(ADP-ribose) polymerases and CD38-family enzymes.
NAD+ 500 mg is presented here as a lyophilized laboratory compound rather than a peptide. Research applications include enzyme assays, redox biochemistry and cellular metabolism studies.
For research use only. Not for human or veterinary use. Published findings describe the compound or related research systems; they are not claims about this NOREXA batch.
HANDLING INFORMATION
The cited data apply to specified NAD+ solutions; an exact storage period has not been established for this formulation.
Sigma-Aldrich — β-NAD aqueous-solution technical data ↗SCIENTIFIC CONTEXT
Longer technical information is grouped for easier reading on desktop and mobile.
NAD+ occurs naturally across biological systems and cycles with its reduced form NADH in central metabolic reactions. Cellular NAD+ pools are also consumed by enzymes involved in protein deacylation, ADP-ribosylation and calcium-related signalling.
NAD+/NADH couples transfer reducing equivalents in metabolic enzyme reactions.
NAD+ availability is linked to the catalytic activity of NAD-dependent deacylases.
PARP and related enzymes consume NAD+ during signalling and DNA-damage responses.
Lyophilized material may require preparation as a laboratory solution before use in an in-vitro assay. The solvent or buffer and working concentration should follow the applicable protocol and documentation for the exact molecular form.
This page intentionally provides no human dosing calculations, syringe-unit conversions, administration route or treatment schedule. Preparation conditions should be established and recorded by qualified laboratory personnel.
INDEPENDENT VERIFICATION
Purity alone is not enough. NOREXA distinguishes identity, purity and actual quantity, and publishes results only for the exact batch tested.
CURRENT BATCH / LOT
No identity, purity, quantity or batch number is shown as independently verified until exact product-and-lot evidence is available.
OPEN CENTRAL BATCH VERIFICATION →HISTORICAL BATCHES
No historical batch records are currently published for this product.
PRODUCT INFORMATION
Verified identity and catalogue information for this NOREXA research material. Unconfirmed fields are omitted.
Batch documentation and independent reports are shown only when published for the exact corresponding batch.
CHEMICAL IDENTITY REFERENCE ↗SELECTED SOURCES
Selected literature describes the compound and relevant research pathways; it does not constitute testing or endorsement of this NOREXA batch.
Cell Metabolism · 2015
Nature Reviews Molecular Cell Biology · 2021
Cell Metabolism · 2018
PRODUCT FAQ
No. NAD+ is a dinucleotide cofactor used in redox chemistry and enzyme signalling.
Yes. NAD+ is an endogenous cellular cofactor found across living systems.
Common research contexts include enzyme kinetics, redox-coupled assays, metabolism and NAD-consuming enzyme systems.
No. It applies only when the free-acid identity and neutral-pH aqueous conditions match the cited technical record.
SECTION 01 — STANDARDS
01 / 03Independent analytical results are presented as reported by the testing laboratory, without altering the laboratory’s findings.
02 / 03Each batch is assigned a record linking the product to its available technical and independent testing documentation.
03 / 03Available batch documentation is organized under the corresponding batch number for clear reference.
NOREXA PEPTIDES
RESEARCH ACCESS
Please confirm before entering the website.
RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE